Indications	APIs	Current Stage	Target (DMF Registration)
Contrast Agent	Ioversol	Finished R&D, Patent Application	2020.4Q
	Iomeprol	Finished R&D, Patent Application Ready for PV	2026.4Q
Antidepressant	Escitalopram Oxalate	Finished R&D, Patent Application, Ready for PV	2019.4Q
Antibiotic	Cefmetazole Na (Powder form)	Finished R&D, Patent Application, Ready for PV	2020.1Q
	Flomoxef Na (Powder form)	Finished R&D, Patent Application Ready for PV	2026.4Q
Multiple Sclerosis	Ozanimod	R&D	2028.4Q
Antibiotic	Tigecycline	R&D	2028.4Q
Autoimmune Disease Janus kinase (JAK) inhibitor	Upadacitinib	R&D	2028.4Q
Anticancer Drug	Antibody-Drug Conjugates(ADC)	R&D	2028.4Q

Dosage form	Pipeline	Items & Plan
Injection (Injectable KIT)	IR-IV	Pain/Inflammation
	IR-IV complexes	Total Parenteral Nutrition
		NSAIDs-complexes
Pre-Filled Syringe PFS	LA-SC	Skin booster Whitening
Oral Solid Dosage form (OSDF)	ER-GI	Extended-release NSAIDs
	Generic&Modified Drug	Gastroesophageal reflux disease Obesity Others

Product Group	Item	Current Stage
Injection	Prefilled Syringe	Under Development